Stephane Pollentier

1.6k total citations · 1 hit paper
9 papers, 1.1k citations indexed

About

Stephane Pollentier is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Stephane Pollentier has authored 9 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 2 papers in Pharmacology and 2 papers in Clinical Psychology. Recurrent topics in Stephane Pollentier's work include Schizophrenia research and treatment (5 papers), Migraine and Headache Studies (2 papers) and Treatment of Major Depression (2 papers). Stephane Pollentier is often cited by papers focused on Schizophrenia research and treatment (5 papers), Migraine and Headache Studies (2 papers) and Treatment of Major Depression (2 papers). Stephane Pollentier collaborates with scholars based in Germany, United States and Switzerland. Stephane Pollentier's co-authors include Ingo W. Husstedt, Ulrich Meier, Peter J. Goadsby, Lynna M. Lesko, Jes Olesen, David B. Hall, Hans‐Christoph Diener, Richard S.E. Keefe, Jana Podhorná and Michael Desch and has published in prestigious journals such as New England Journal of Medicine, Schizophrenia Bulletin and Progress in Neuro-Psychopharmacology and Biological Psychiatry.

In The Last Decade

Stephane Pollentier

7 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine

2004 945 citations Jes Olesen, Hans‐Christoph Diener et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephane Pollentier Germany	6	904	518	364	274	145	9	1.1k
Song Guo Denmark	20	1.1k 1.2×	561 1.1×	449 1.2×	283 1.0×	201 1.4×	51	1.3k
Anan Srikiatkhachorn Thailand	25	1.0k 1.1×	519 1.0×	557 1.5×	191 0.7×	167 1.2×	71	1.5k
Mohammad Al‐Mahdi Al‐Karagholi Denmark	21	1.2k 1.3×	571 1.1×	412 1.1×	311 1.1×	249 1.7×	60	1.5k
Agustin Melo‐Carrillo United States	18	1.2k 1.3×	618 1.2×	449 1.2×	267 1.0×	293 2.0×	32	1.5k
Boukje de Vries Netherlands	21	962 1.1×	281 0.5×	254 0.7×	234 0.9×	277 1.9×	36	1.3k
Roberto Marconi Italy	18	706 0.8×	220 0.4×	236 0.6×	400 1.5×	199 1.4×	29	1.8k
Samaira Younis Denmark	19	1.1k 1.3×	554 1.1×	338 0.9×	80 0.3×	183 1.3×	32	1.3k
Nazia Karsan United Kingdom	19	846 0.9×	420 0.8×	315 0.9×	64 0.2×	148 1.0×	50	992
Margarida Martins-Oliveira United States	6	1.2k 1.4×	559 1.1×	408 1.1×	111 0.4×	238 1.6×	8	1.4k
LH Lassen Denmark	10	1.4k 1.6×	782 1.5×	694 1.9×	267 1.0×	288 2.0×	10	1.6k

Countries citing papers authored by Stephane Pollentier

Since Specialization

Citations

This map shows the geographic impact of Stephane Pollentier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephane Pollentier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephane Pollentier more than expected).

Fields of papers citing papers by Stephane Pollentier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephane Pollentier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephane Pollentier. The network helps show where Stephane Pollentier may publish in the future.

Co-authorship network of co-authors of Stephane Pollentier

This figure shows the co-authorship network connecting the top 25 collaborators of Stephane Pollentier. A scholar is included among the top collaborators of Stephane Pollentier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephane Pollentier. Stephane Pollentier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Fleischhacker, W. Wolfgang, Jana Podhorná, Yihua Zhao, et al.. (2021). Efficacy and safety of the novel glycine transporter inhibitor BI 425809 once daily in patients with schizophrenia: a double-blind, randomised, placebo-controlled phase 2 study. The Lancet Psychiatry. 8(3). 191–201. 96 indexed citations

2.

Bilderbeck, Amy C., Dennis Hernaus, Anja Hayen, et al.. (2020). Optimizing Behavioral Paradigms to Facilitate Development of New Treatments for Anhedonia and Reward Processing Deficits in Schizophrenia and Major Depressive Disorder: Study Protocol. Frontiers in Psychiatry. 11. 536112–536112. 3 indexed citations

3.

Keefe, Richard S.E., Scott W. Woods, Tyrone D. Cannon, et al.. (2020). A randomized Phase II trial evaluating efficacy, safety, and tolerability of oral BI 409306 in attenuated psychosis syndrome: Design and rationale. Early Intervention in Psychiatry. 15(5). 1315–1325. 7 indexed citations

4.

Porcelli, Stefano, Siegfried Kasper, Joseph Zohar, et al.. (2019). Social dysfunction in mood disorders and schizophrenia: Clinical modulators in four independent samples. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 99. 109835–109835. 32 indexed citations

5.

Podhorná, Jana, et al.. (2019). S27. EFFICACY, SAFETY, AND PHARMACOKINETICS OF BI 425809 ONCE DAILY IN PATIENTS WITH SCHIZOPHRENIA: METHODOLOGY OF A RANDOMIZED TRIAL. Schizophrenia Bulletin. 45(Supplement_2). S315–S316. 1 indexed citations

6.

Wunderlich, Glen, Kenneth Evans, Terrence Sills, et al.. (2005). An item response analysis of the international restless legs syndrome study group rating scale for restless legs syndrome. Sleep Medicine. 6(2). 131–139. 33 indexed citations

7.

Olesen, Jes, et al.. (2004). Calcitonin gene-related peptide receptor antagonist BIBN4096BSfor the acute treatment of migraine. UCL Discovery (University College London). 1 indexed citations

8.

Olesen, Jes, Hans‐Christoph Diener, Ingo W. Husstedt, et al.. (2004). Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine. New England Journal of Medicine. 350(11). 1104–1110. 945 indexed citations breakdown →

9.

Pollentier, Stephane. (1992). [How erythrophobia became social phobia. An overview of the clinical-diagnostic topic].. PubMed. 63(1). 28–33. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact